THY1 and cancer: Additionally, the genes that are distinctly expressed in liver CD90+CSCs but not in CD90+NTSCs, such as GPC3, could be promising candidates for immunotherapy, which could eliminate liver cancer stem cells and adult cancer cells without inducing damage to normal liver cells.